Two cases of mumps, a vaccine preventable communicable viral disease, were identified in Morgan County.
Mumps, an acute vaccine-preventable viral illness transmitted by respiratory droplets and saliva, has an incubation period of 16–18 days (12–25 days min/max respectively). A statewide notification is being sent since the cases are widespread across the Morgan County community and a common exposure has not been identified. Continue reading →
In our effort to enhance patient and healthcare provider safety, last year Centegra Health System (CHS) made the influenza vaccination mandatory for all Associates. The program was a huge success in vaccinating over 95% of associates. This season all physicians are expected to participate in this Medical Executive Committee (MEC) approved initiative to increase our patient safety.
Research shows that vaccination is the single most important measure for reducing the impact of influenza not only on ourselves but our community as well. It is therefore our responsibility as healthcare workers to do the right thing for our patients. The Center for Disease Control, IDPH and The Joint Commission both highly recommend flu shots for all health care workers and many progressive healthcare organizations both locally and nationally have seen positive outcomes as a result of mandatory flu shot programs.
CHS requires all associates, physicians, volunteers, students, clinical contract workers, and identified vendors to receive an influenza vaccination in order to protect patients, Associates, family members, and the community from influenza. Exceptions will only be granted for medical conditions and religious beliefs. Both will require written documentation. Associates previously granted exemptions are required to complete a exemption renewal. Please review the updated CHS Influenza Immunization Program policy for details.
The risk of Guillain-Barre is often viewed as an obstacle to influenza vaccination.
A recent study by Kwong et al published in the June 28th issue of the Lancet identified cases of Guillain-Barre that occurred with 6 weeks of vaccination and found that more cases occurred in the control group (not vaccinated) than in those who were vaccinated. Far greater number of Guillain-Barre cases were identified in the non-vaccinated group than in the ones vaccinated.
The conclusion reached was that the attributable risk for Guillain-Barre after seasonal inflluenza vaccination is lower than those after influenza disease itself. This study was funded by the Canadian Institute of Health Research.
Since the introduction of 7-valent pneumoccal vaccine (PCV 7) in the US immunization schedule there has been a steady decline in the number of invasive pneumococcal disease as reported in the July 11th issue of the New England Journal of Medicine by Griffen et al. The annual rate of hospitalization for pneumonia among children younger than 2 years of age declined by 551.1 per 100,000 children (95% confidence interval [CI], 445.1 to 657.1), which translates to 47,000 fewer hospitalizations annually than expected on the basis of the rates before PCV7 was introduced. The rate for adults 85 years of age or older declined by 1300.8 per 100,000 (95% CI, 984.0 to 1617.6), which translates to 73,000 fewer hospitalizations annually. For the three age groups of 18 to 39 years, 65 to 74 years, and 75 to 84 years, the annual rate of hospitalization for pneumonia declined by 8.4 per 100,000 (95% CI, 0.6 to 16.2), 85.3 per 100,000 (95% CI, 7.0 to 163.6), and 359.8 per 100,000 (95% CI, 199.6 to 520.0), respectively. Overall, we estimated an age-adjusted annual reduction of 54.8 per 100,000 (95% CI, 41.0 to 68.5), or 168,000 fewer hospitalizations for pneumonia annually.